Cargando…
Characterization of novel carcinoma cell lines for the analysis of therapeutical strategies fighting pancreatic cancer
BACKGROUND: Preclinical evaluations of chemotherapies depend on clinically relevant animal models for pancreatic cancer. The injection of syngeneic murine adenocarcinoma cells is one efficient option to generate carcinomas in mice with an intact immune system. However, this option is constrained by...
Autores principales: | Zechner, Dietmar, Bürtin, Florian, Amme, Jonas, Lindner, Tobias, Radecke, Tobias, Hadlich, Stefan, Kühn, Jens-Peter, Vollmar, Brigitte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551666/ https://www.ncbi.nlm.nih.gov/pubmed/26322225 http://dx.doi.org/10.1186/s13578-015-0038-6 |
Ejemplares similares
-
Impact of diabetes type II and chronic inflammation on pancreatic cancer
por: Zechner, Dietmar, et al.
Publicado: (2015) -
Metformin Inhibits Gemcitabine Induced Apoptosis in Pancreatic Cancer Cell Lines
por: Zechner, Dietmar, et al.
Publicado: (2017) -
Analysis of Axin2 expression and function in murine models for pancreatic cancer
por: Zechner, Dietmar, et al.
Publicado: (2016) -
Intratumoral heterogeneity of the therapeutical response to gemcitabine and metformin
por: Zechner, Dietmar, et al.
Publicado: (2016) -
Blocking Autophagy in Cancer-Associated Fibroblasts Supports Chemotherapy of Pancreatic Cancer Cells
por: Zhang, Xianbin, et al.
Publicado: (2018)